milhalopoulos-livingwith-2011.pdf (367.29 kB)
Download file

Living with prostate cancer: randomised controlled trial of a multimodal supportive care intervention for men with prostate cancer

Download (367.29 kB)
journal contribution
posted on 01.01.2011, 00:00 authored by S Chambers, R Newton, A Girgis, L Nielsen, S Lepore, Cathy Mihalopoulos, R Gardiner, D Galvao, S Occhipinti
Background: Prostate cancer is the most common male cancer in developed countries and diagnosis and treatment carries with it substantial morbidity and related unmet supportive care needs. These difficulties may be amplified by physical inactivity and obesity. We propose to apply a multimodal intervention approach that targets both unmet supportive care needs and physical activity.
Methods/design: A two arm randomised controlled trial will compare usual care to a multimodal supportive care intervention “Living with Prostate Cancer” that will combine self-management with tele-based group peer support. A series of previously validated and reliable self-report measures will be administered to men at four time points: baseline/recruitment (when men are approximately 3-6 months post-diagnosis) and at 3, 6, and 12 months after recruitment and intervention commencement. Social constraints, social support, self-efficacy, group cohesion and therapeutic alliance will be included as potential moderators/mediators of intervention effect. Primary outcomes are unmet supportive care needs and physical activity levels. Secondary outcomes are domain-specific and healthrelated quality of life (QoL); psychological distress; benefit finding; body mass index and waist circumference. Disease variables (e.g. cancer grade, stage) will be assessed through medical and cancer registry records. An economic evaluation will be conducted alongside the randomised trial.
Discussion: This study will address a critical but as yet unanswered research question: to identify a populationbased way to reduce unmet supportive care needs; promote regular physical activity; and improve disease-specific and health-related QoL for prostate cancer survivors. The study will also determine the cost-effectiveness of the intervention.



BMC cancer




Article no. 317

Article number



1 - 8


BioMed Central Ltd


London, England





Publication classification

C1 Refereed article in a scholarly journal

Copyright notice

2011, The Authors